Study of Late-Occurring Complications in Childhood Cancer Survivors


Cancer Survivor | Cardiovascular Complications | Hematopoietic/Lymphoid Cancer | Unspecified Childhood Solid Tumor, Protocol Specific

What is the purpose of this trial?

This clinical trial is studying cancer survivors to identify those who are at increased risk of developing late-occurring complications after undergoing treatment for childhood cancer. A patient's genes may affect the risk of developing complications, such as congestive heart failure, heart attack, stroke, and second cancer, years after undergoing cancer treatment. Genetic studies may help doctors identify survivors of childhood cancer who are more likely to develop late complications.

Participation Guidelines

Up to 21 Years

Click here for detailed information about who can participate in this trial.

Children's Oncology Group
National Cancer Institute (NCI)
March 2004
Last Updated:
August 21, 2014
Study HIC#:
0412027286 ID: NCT00082745